Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials-Reference-Cited by-同舟云学术

Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials

Published:2020-04-28 Issue: Volume: Page:
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Madelain Vincent¹,Mentré France¹,Baize Sylvain²,Anglaret Xavier³⁴,Laouénan Cédric¹,Oestereich Lisa⁵⁶,Nguyen Thi Huyen Tram¹,Malvy Denis³⁷,Piorkowski Géraldine⁸,Graw Frederik⁹,Günther Stephan⁵⁶,Raoul Hervé¹⁰,Lamballerie Xavier⁸,Guedj Jérémie¹

Affiliation:

1. Université de Paris IAME INSERM Paris France

2. UBIVE Institut Pasteur Centre International de Recherche en Infectiologie Lyon France

3. INSERM UMR 1219 Université de Bordeaux Bordeaux France

4. Programme PACCI/site ANRS de Côte d’Ivoire Abidjan Côte d’Ivoire

5. Bernhard‐Nocht‐Institute for Tropical Medicine Hamburg Germany

6. German Center for Infection Research (DZIF) Partner Site Hamburg Germany

7. Centre Hospitalier Universitaire de Bordeaux Bordeaux France

8. UMR "Emergence des Pathologies Virales" (EPV: Aix‐Marseille University – IRD 190 – Inserm 1207 – EHESP) – Institut Hospitalo‐Universitaire Méditerranée Infection Marseille France

9. Center for Modeling and Simulation in the Biosciences (BIOMS) BioQuant‐Center Heidelberg University Heidelberg Germany

10. Laboratoire P4 Inserm‐Jean Mérieux US003 Inserm Lyon France

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12510

Reference93 articles.

1. Emerging Viral Diseases: Confronting Threats with New Technologies

2. Human viruses: discovery and emergence

3. Approved Antiviral Drugs over the Past 50 Years